Metraipolis › archive › dc_252dc6458d41

Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations — Europe PMC PMID:41138165

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41138165
DOI
10.1093/oncolo/oyaf362
License (as archived)
solo-consultazione
Archived
2026-11-08T21:18:59.773Z
SHA-256 of the archived text
6b3395c081bb1bf0fd94c6c7d8137217f5c01ab8923dd1d24ec12f1646adc920
Stable URL of this page
https://metraipolis.com/documento/dc_252dc6458d41

How to cite

Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations — Europe PMC PMID:41138165 — Europe PMC (en), https://europepmc.org/article/MED/41138165 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_252dc6458d41 (Metraipolis archive dc_252dc6458d41, sha256 6b3395c081bb1bf0fd94c6c7d8137217f5c01ab8923dd1d24ec12f1646adc920)
BibTeX
@misc{dc252dc6458d41,
  title = {Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations — Europe PMC PMID:41138165},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41138165},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_252dc6458d41; sha256 6b3395c081bb1bf0fd94c6c7d8137217f5c01ab8923dd1d24ec12f1646adc920},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41138165. Agents can read the archived copy with the MCP tool read_document.